PATENT CLAIM ANALYSIS

Application Number: 15898683
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["514", "312000"]

Abstract:
The present invention relates to pharmaceutical compositions comprising a compound of Formula I in combination with one or both of a Compound of Formula II and/or a Compound of Formula III. The invention also relates to solid forms and to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis.

Claim (Index 9):
A method of treating a CFTR mediated disease in a human, wherein the method comprises administering to the human an effective amount of the pharmaceutical composition of  claim 8 .

Metadata:
- Claim Count in Document: 6.0
- Percentile: 88.0
- Lexical Diversity: 1.52381
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12909750', '13678840', '14200656', '12909789', '13751656']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8044600761629618
- 35 USC 102 Novelty (BERT): 0.5595792251506843
- Combined Prediction Score: 0.779971991061734
- Mean Citation Score: 280.55019000000004
- Max Citation Score: 284.113
- Similarity Product: 167.54715528523926

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test